Chou SC, Chen KW, Hwang JS, et al
95% CI -10.78 to -1.10
BPC-157 , a synthetic peptide derived from a protective protein found in gastric juice, has been widely explored in laboratory settings for its potential influence on angiogenesis, cytoprotection, and tissue repair mechanisms
In people with obesity and established cardiovascular disease but without diabetes, semaglutide 2.4 mg resulted in 20% reduction in major adverse cardiovascular events [(MACE), death from cardiovascular causes, nonfatal myocardial infarction or nonfatal stroke] compared to placebo (SELECT trial) after a mean follow-up of 39.8 months this is the first trial demonstrating cardiovascular benefit for an obesity pharmacotherapy [110]
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology
Injectable GHK-Cu is not FDA-approved for human/therapeutic use and is sold by suppliers under "research use only" labeling